REGENXBIO, Inc. (RGNX)
8.05
-0.09
(-1.11%)
USD |
NASDAQ |
Feb 23, 11:23
REGENXBIO Market Cap : 407.52M for Feb. 23, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Sarepta Therapeutics, Inc. | 1.904B |
| Omeros Corp. | 791.96M |
| AbbVie, Inc. | 404.36B |
| CytomX Therapeutics, Inc. | 940.37M |
| Krystal Biotech, Inc. | 7.627B |
Market Cap Related Metrics
| PS Ratio | 2.547 |
| Price to Book Value | 2.524 |
| Price | 8.05 |
| Earnings Yield | -43.35% |